statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	740
RU - Federazione Russa	216
IT - Italia	148
SG - Singapore	131
CN - Cina	120
VN - Vietnam	108
GB - Regno Unito	78
IE - Irlanda	73
HK - Hong Kong	49
DE - Germania	47
FR - Francia	47
BR - Brasile	46
IN - India	28
SE - Svezia	26
FI - Finlandia	24
KR - Corea	22
BD - Bangladesh	19
ES - Italia	11
NL - Olanda	11
UA - Ucraina	11
IQ - Iraq	10
JP - Giappone	10
MX - Messico	10
PL - Polonia	10
ZA - Sudafrica	10
CA - Canada	9
RS - Serbia	8
CZ - Repubblica Ceca	4
PK - Pakistan	4
PY - Paraguay	4
VE - Venezuela	4
AR - Argentina	3
CH - Svizzera	3
EG - Egitto	3
GR - Grecia	3
IR - Iran	3
JO - Giordania	3
KE - Kenya	3
MY - Malesia	3
TR - Turchia	3
UZ - Uzbekistan	3
AT - Austria	2
CY - Cipro	2
LK - Sri Lanka	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AZ - Azerbaigian	1
BE - Belgio	1
BG - Bulgaria	1
BN - Brunei Darussalam	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
DK - Danimarca	1
ET - Etiopia	1
GT - Guatemala	1
HU - Ungheria	1
JM - Giamaica	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MA - Marocco	1
MK - Macedonia	1
NI - Nicaragua	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PT - Portogallo	1
SA - Arabia Saudita	1
SC - Seychelles	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
UG - Uganda	1
Totale	2.108

Nome	#
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients	303
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype?	262
Biomarkers in COVID-19 pandemic: implications for acute phase assessment and chronic management	252
Non-neoplastic asbestos-related respiratory diseases: what relationship with other lung diseases?	213
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female	212
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19	210
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis	190
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases	184
Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae	153
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis	97
Biomarkers of Sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme and KL-6	68
Totale	2.144

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	6	0	0	0	0	0	0	0	0	0	0	0	6
2021/2022	80	1	8	7	2	3	1	7	6	5	12	13	15
2022/2023	143	6	19	20	24	7	24	8	15	11	6	0	3
2023/2024	193	9	1	8	8	6	39	38	8	11	25	8	32
2024/2025	463	28	28	49	26	47	31	49	26	32	29	37	81
2025/2026	1.032	66	118	103	138	191	35	171	27	34	67	60	22
Totale													2.144